Accepted at 1:09 p.m. Apr, 04, 2024 by Sameem
Author: Cameron
Co-authors: herstein.jacob
Related Note: 1462849382382
Rationale for change

Shortened text and corrected implication that metabolism does not occur in the liver; sulfonylureas are also contraindicated in liver failure and are thought to be entirely metabolized by the liver with most excretion done by the kidney > feces

Sulfonylureas section; contraindications: https://next.amboss.com/us/article/7m04Sg?q=sulfonylureas#nWc7NY0

Example pharmacokinetics section: https://next.amboss.com/us/pharma/glipizide?q=sulfonylureas

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#B&B::04_Endocrinology::03_Diabetes::05_Diabetes_Treatment::Extra #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#OME::04_Organ_Systems::06_Endocrine::05_Pancreas::03_Diabetes_Pharmacology #AK_Step1_v12::#OME::PreClinical::04_Organ_Systems::06_Endocrine::05_Pancreas::03_Diabetes_Pharmacology #PANCE::EOR::PEDS #AK_Step2_v12::#SketchyIM::05_Endocrinology::01_Diabetes_Mellitus::02_Diabetes_Management #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::02_Diabetes::01_Insulin,_sulfonylureas,_meglitinides,_GLP-1_agonists,_DPP-4_inhibitors #AK_Step1_v12::#Pixorize::03_Pharmacology::07_Diabetes_Drugs_(New)::07_Sulfonylureas #AK_Step1_v12::#UWorld::Step::15308 #AK_Step1_v12::^Systems::Endocrine::Pharmacology #AK_Step1_v12::#Bootcamp::Endocrinology::07_Pancreas::09_Diabetes_Type_2_Management #AK_Step1_v12::#Pixorize::03_Pharmacology::08_Diabetes_Drugs_(Old)::05_Second-Gen_Sulfonylureas #AK_Step1_v12::#Pixorize::03_Pharmacology::08_Diabetes_Drugs_(Old)::04_First-Gen_Sulfonylureas #PANCE::ENDO::diabetes #AK_Step1_v12::#Physeo::09_Pharm::07_Endocrine::04_Sulfonylureas_and_Meglitinides #AK_Step1_v12::#FirstAid::08_Endocrine::05_Pharm::01_Diabetes_mellitus_therapy::*Sulfonylureas #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#UWorld::COMLEX::26230 #AK_Step1_v12::#AMBOSS::i0aJfQ